A dose of 500 mg daily sits at the bottom of metformin’s typical dosing range, and most clinical trials studying weight loss have used higher amounts, usually 1,500 to 2,550 mg per day. That said, even 500 mg is not without effect. A meta-analysis of metformin in obesity found that both low-dose and high-dose regimens reduced BMI, though the higher doses produced a larger drop. Whether 500 mg is “enough” depends on why you are taking it, how your body tolerates it, and what your prescriber plans to do with the dose over time.
Where 500 mg Falls in the Dosing Range
Metformin is commonly prescribed in tablets of 500 mg, 850 mg, or 1,000 mg. For diabetes management, the usual target is 1,500 to 2,000 mg per day, split across meals. For weight loss specifically, studies have tested doses anywhere from 500 mg to 2,550 mg daily. Nearly every prescribing protocol starts at 500 mg once or twice daily and increases from there, making 500 mg less a treatment dose and more a ramp-up dose. Clinical guidelines for conditions like polycystic ovary syndrome recommend beginning at 500 mg twice daily and adding 500 mg each week until reaching the maximum tolerated dose.1European Journal of Endocrinology. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
So if your doctor has you on 500 mg and hasn’t mentioned going higher, it is worth asking whether that’s the intended maintenance dose or just the starting point. Many people stay at 500 mg because their GI tract protests anything higher, and that is a legitimate reason. But the research generally favors higher doses for more meaningful weight loss.
What the Evidence Says About Dose and Weight Loss
A meta-analysis looking at metformin across different populations found that higher doses produced a bigger BMI reduction (about 1 unit) compared with lower doses (about 0.9 units), though both were statistically meaningful.2PubMed Central. Effects of metformin in obesity treatment in different populations: a meta-analysis That gap is relatively small, which is part of why the dose question is more nuanced than it first appears.
A separate review that pooled data from 21 randomized trials found no significant dose-response relationship within the ranges studied, but did find a clear time-course relationship: the longer someone stayed on metformin, the more weight they lost.3PubMed. Time course and dose effect of metformin on weight in patients with different disease states In other words, sticking with the medication over months may matter more than cramming in extra milligrams.
One study that directly compared doses in women with PCOS gave one group 1,500 mg per day and another 2,550 mg per day. Among obese participants, the higher-dose group lost more weight (about 3.6 kg versus 1.5 kg). But among the most severely obese participants, the two dose groups lost nearly identical amounts, around 3.8 to 3.9 kg.4The Journal of Clinical Endocrinology & Metabolism. Metformin and Weight Loss in Obese Women with Polycystic Ovary Syndrome: Comparison of Doses This hints that body size itself influences how much benefit you get from dose escalation, and that higher doses don’t always translate into proportionally more weight loss.
How Metformin Actually Promotes Weight Loss
Metformin was designed to lower blood sugar, not to shed pounds. The weight loss it produces is more of a welcome side effect, driven by several overlapping mechanisms rather than one clean pathway.
One of the better-understood mechanisms involves a hormone called GDF15. Metformin raises levels of this circulating peptide, which acts on receptors in the brainstem to suppress appetite and reduce food intake. Two independent randomized controlled trials confirmed that metformin increases GDF15 levels and that this hormone is necessary for metformin’s effects on energy balance and body weight.5Nature. GDF15 mediates the effects of metformin on body weight and energy balance Mouse studies showed that when GDF15 was genetically removed, metformin’s ability to reduce food intake and body mass disappeared entirely, even though its blood-sugar-lowering effect remained intact.6PubMed. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss
Metformin also works through the gut. It boosts secretion of GLP-1, the same gut hormone that newer injectable weight-loss drugs (like semaglutide) mimic at much higher potencies.7Frontiers in Pharmacology. Understanding the action mechanisms of metformin in the gastrointestinal tract It alters the composition of gut bacteria and influences bile acid handling, both of which affect how glucose gets absorbed and used.8PubMed Central. Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review
At the cellular level, metformin activates an energy sensor called AMPK, which flips metabolic switches that reduce fat production in the liver and improve the body’s sensitivity to insulin.9Nature Medicine. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin This chain of events, blocking fatty acid synthesis and promoting fat burning, is a meaningful contributor to weight loss, especially in people who already have significant insulin resistance.10PubMed Central. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
Does It Work If You Don’t Have Diabetes?
Yes, and the weight loss appears roughly the same. A retrospective study comparing people with normal blood sugar to those with type 2 diabetes or prediabetes found nearly identical weight loss in both groups. At six months, both groups averaged about 6.5% of their starting weight lost. At twelve months, the numbers were still similar: around 7.3–7.4%.11Obesity Research & Clinical Practice. Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study That undercuts the common belief that metformin only helps with weight if your metabolism is already impaired.
A study of non-diabetic individuals with obesity reported an average weight loss of about 5.8 kg with metformin treatment, while untreated controls actually gained weight. People with more severe insulin resistance lost more.12PubMed. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity A systematic review and meta-analysis of randomized trials in obese non-diabetic patients found that metformin produced a modest but consistent drop in BMI at doses ranging from 500 to 2,550 mg daily, with no significant interaction between dose and effect.13PubMed. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials That last finding is especially relevant if you’re taking 500 mg: across pooled trial data, the dose you’re on didn’t clearly underperform the higher ones.
The GI Problem and Why Many People Stay at 500 mg
The most common reason people stay on a low dose is that their stomach will not tolerate more. Metformin can cause nausea, diarrhea, bloating, and abdominal cramps, and these side effects affect up to about one in five users.14The British Journal of Diabetes & Vascular Disease. Review: Optimal dosing strategies for maximising the clinical response to metformin in type 2 diabetes Starting low and titrating slowly is the standard advice, but for some people, even that does not prevent gut trouble, and it can be hard to convince someone to try again after a bad bout of GI symptoms.15PubMed. Understanding and overcoming metformin gastrointestinal intolerance
If you are stuck at 500 mg because of side effects, extended-release (XR) metformin may be worth discussing with your prescriber. Trials comparing immediate-release to extended-release formulations found that the XR version causes significantly fewer adverse events at both three and six months.16PubMed Central. Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes Switching to XR can sometimes allow people to tolerate the higher doses needed for more robust weight loss, without the GI misery that kept them at 500 mg.
How Metformin Compares to Newer Weight-Loss Drugs
Metformin’s weight loss is real but modest compared to the GLP-1 receptor agonists that have dominated recent headlines. In a pilot study of patients gaining weight on antipsychotic medications, semaglutide produced an average loss of about 4.5 kg over 16 weeks versus about 2.9 kg with metformin. That works out to roughly 4% versus 2.5% of body weight, and the difference between the two drugs did not reach statistical significance in this small trial.17PubMed Central. Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study
A study comparing metformin to beinaglutide (a GLP-1 agonist used in China) in overweight and obese non-diabetic patients found a starker contrast: the GLP-1 group lost about 9.1 kg versus 4.5 kg in the metformin group. About 91% of the GLP-1 group lost at least 5% of body weight, compared to 47% of the metformin group.18PubMed Central. Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients
Where metformin still holds a strong card is cost. Monthly costs for GLP-1 agonists can run into hundreds or even thousands of dollars, while metformin is among the cheapest prescription drugs available. A cost-effectiveness analysis of antiobesity drugs for adolescents with severe obesity found that metformin compared favorably to other options on price, even though it is not FDA-approved specifically for weight loss.19JAMA Network Open. Cost-Effectiveness of Antiobesity Drugs for Adolescents With Severe Obesity For people who cannot access or afford the newer medications, metformin remains a reasonable option.
Duration Matters More Than You Might Expect
The Diabetes Prevention Program, one of the largest and longest-running studies involving metformin, followed participants for over a decade. Among those who lost at least 5% of their weight in the first year on metformin, more than half maintained that loss across the entire 15-year follow-up. Weight loss in the metformin group held steady at around 6.2% below baseline between years six and fifteen, which actually exceeded the loss maintained by the intensive lifestyle intervention group over the same period.20PubMed Central. Long-term Weight Loss with Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study Critically, the degree of continuing weight loss was tied to how consistently people actually took their metformin.21PubMed Central. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study
This is one reason the dose question is not the whole story. If you tolerate 500 mg well enough to take it reliably every day for years, that consistency may do more for your weight than a higher dose you abandon after two months because of side effects.
What Happens When You Stop
Weight regain after stopping metformin is common and fairly quick. A study of women with PCOS found that those who had been on short-term metformin regained a significant amount of weight after discontinuation, going from a median of about 92 kg up to 96 kg. Long-term users also trended toward regain, though the rebound was less dramatic.22PubMed Central. Effects of metformin withdrawal after long and short term treatment in PCOS: observational longitudinal study This pattern is not unique to metformin. Most pharmacological weight loss interventions show some degree of rebound once the drug is removed. It is worth going in with the understanding that metformin for weight management is generally a long-term commitment, not a short course.
Combining Metformin With Lifestyle Changes
Metformin and lifestyle modification are not an either/or choice, and the combination tends to outperform either alone. A study in obese adolescents found that adding metformin to lifestyle changes (diet and exercise counseling) produced significantly more weight loss than lifestyle changes by themselves.23PubMed. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents If you are on 500 mg and want to maximize your results without necessarily increasing your dose, pairing the medication with dietary changes and regular physical activity is the highest-impact move available.
Vitamin B12 and Long-Term Safety
One issue worth knowing about if you plan to stay on metformin for an extended period: it can lower your vitamin B12 levels. A randomized placebo-controlled trial found that metformin treatment was associated with a roughly 19% decrease in B12 concentration compared to placebo, with the absolute risk of B12 deficiency about 7 percentage points higher in the metformin group over about four years.24PubMed. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial Data from the Diabetes Prevention Program echoed this: low B12 was more common in the metformin group at five years, and each additional year on metformin increased the odds of deficiency.25PubMed Central. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study The risk appears to be higher with longer use and higher doses.26PubMed Central. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind
B12 deficiency can cause fatigue, numbness or tingling in the hands and feet, and cognitive changes. At 500 mg the risk is lower than at 2,000 mg, but periodic monitoring of B12 levels is a sensible precaution for anyone on metformin long-term, regardless of dose.
Age and Metformin’s Effectiveness
Metformin does not appear to work equally well at every age. In the Diabetes Prevention Program, participants aged 60 to 85 actually lost the most weight overall, but metformin’s effectiveness at preventing diabetes diminished with age. After adjusting for that greater weight loss, the risk of developing diabetes still increased with age in the metformin group, suggesting that age-related changes in insulin dynamics may blunt metformin’s metabolic benefits even when weight comes off.27The Journals of Gerontology: Series A. The Influence of Age on the Effects of Lifestyle Modification and Metformin in Prevention of Diabetes For older adults considering metformin primarily for weight management, this is a reason to have realistic expectations and to think of metformin as one tool among several rather than a standalone solution.
When You Take It May Also Matter
An emerging area of research involves the timing of metformin doses relative to your body’s internal clock. A pharmacokinetic study found significant time-of-day variation in how metformin is absorbed and cleared. Individual chronotype, meaning whether you are naturally an early riser or a night owl, also affected metformin concentrations in the blood, with kidney filtration rate and transporter activity fluctuating across the day.28PubMed Central. Significant impact of time-of-day variation on metformin pharmacokinetics This research is still early-stage, and there are no firm clinical guidelines yet on optimal dosing time. But it suggests that when you take your 500 mg pill could influence how much of the drug actually reaches effective levels in your tissues, which is an interesting variable for a dose that is already on the low end.
For now, the practical takeaway is to take metformin with food (to reduce stomach upset) and at the same time each day. If the science on chronotherapy matures, future dosing recommendations may get more specific about morning versus evening timing based on individual sleep-wake patterns.